|Bid||20.54 x 1000|
|Ask||20.56 x 800|
|Day's Range||19.81 - 20.64|
|52 Week Range||4.95 - 24.76|
|Beta (5Y Monthly)||2.46|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 07, 2020 - Aug 11, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||39.33|
TG Therapeutics (TGTX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does TG Therapeutics (TGTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]